Results 271 to 280 of about 152,498 (307)
Some of the next articles are maybe not open access.

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)

Annals of Oncology, 2010
Gerhardt Attard, L R Molife, P C Fong
exaly  

Histone Deacetylase Inhibitors as Anticancer Drugs

International Journal of Molecular Sciences, 2017
Marie Stiborová   +2 more
exaly  

INHIBITOR OF HISTONE DEACETYLASE

2005
MORADEI OSCAR   +7 more
openaire   +4 more sources

Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility

American Journal of Obstetrics and Gynecology, 2008
Mark Philip Hehir   +2 more
exaly  

Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

Cancer Chemotherapy and Pharmacology, 2012
M. Dong   +9 more
semanticscholar   +1 more source

Inhibitors of histone deacetylase as antitumor agents: A critical review

Bioorganic Chemistry, 2016
Moola Joghee Nanjan, M J N Chandrasekar
exaly  

The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy?

EMBO Reports, 2005
Geneviève Almouzni   +2 more
exaly  

Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy.

Molecular Pharmaceutics, 2012
Jun Yang   +5 more
semanticscholar   +1 more source

Combination therapy: Histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer

Cancer Letters, 2013
Michael L. Granda, Jacob M. Hooker
exaly  

Inhibitors of histone deacetylase

2005
DELORME DANIEL, ZHOU ZHIHONG
openaire   +6 more sources
medicine
biology
histone deacetylase
chemistry
epigenetics
diseases of the blood and blood-forming organs
environmental science
histone acetylation
alzheimer’s disease
previous   26  27  28  29  30  31  

Home - About - Disclaimer - Privacy